期刊的影响因子--文章列表

期刊文章列表
Xin Tang^1,2，Chuanxi Wang³，Lei Wang^4,5，Feifei Ren²，Runqiao Kuang³，Zhenhua Li^1,2，Xue Han³，Yiming Chen²，Guodong Chen³，Xiuqing Wu²，Jie Liu⁴，Hengwen Yang²，Xingzhong Liu⁶，Chen Wang⁴，Hao Gao³，Zhinan Yin^1,2（Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment，Zhuhai Institute of Translational Medicine，Zhuhai People's Hospital Affiliated with Jinan University，Jinan University；Biomedical Translational Research Institute，Health Science Center (School of Medicine)，Jinan University；Institute of Traditional Chinese Medicine and Natural Products，College of Pharmacy/Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China，Jinan University；Department of Respirology，Capital Medical University；Department of Respiratory and Critical Care Medicine，the Second Affiliated Hospital of Xi'an Jiaotong University (Xibei Hospital)；State Key Laboratory of Mycology，Institute of Microbiology，Chinese Academy of Sciences）.Aureane-type sesquiterpene tetraketides as a novel class of immunomodulators with interleukin-17A inhibitory activity[J].Acta Pharmaceutica Sinica B,2023,第9期 Xudong Xing，Mengru Sun，Zifan Guo，Yongjuan Zhao，Yuru Cai，Ping Zhou，Huiying Wang，Wen Gao，Ping Li，Hua Yang（State Key Laboratory of Natural Medicines，School of Traditional Chinese Pharmacy，China Pharmaceutical University）.Functional annotation map of natural compounds in traditional Chinese medicines library：TCMs with myocardial protection as a case[J].Acta Pharmaceutica Sinica B,2023,第9期 Chen Hu^1,2，Lijuan Shen^1,3，Fengming Zou^1,2，Yun Wu^1,2，Beilei Wang^1,2，Aoli Wang^1,2，Chao Wu⁴，Li Wang^1,2，Jing Liu^1,3,2，Wenchao Wang^1,3,2，Qingsong Liu^1,3,2,5（Anhui Province Key Laboratory of Medical Physics and Technology，Institute of Health and Medical Technology，Hefei Institutes of Physical Science，Chinese Academy of Sciences；Hefei Cancer Hospital，Chinese Academy of Sciences；University of Science and Technology of China；Tarapeutics Science Inc.；Precision Medicine Research Laboratory of Anhui Province）.Predicting and overcoming resistance to CDK9 inhibitors for cancer therapy[J].Acta Pharmaceutica Sinica B,2023,第9期 Zhicheng Liu^1,2，Zhuolei Han³，Xin Jin⁴，Jusung An⁵，Jaewon Kim⁵，Wenting Chen⁶，Jong Seung Kim⁵，Ji Zheng^1,2，Jun Deng³（Department of Urology，Xinqiao Hospital，Third Military Medical University (Army Medical University)；Department of Urology，Urological Surgery Research Institute，Southwest Hospital，Third Military Medical University (Army Medical University)；Institute of Burn Research，Southwest Hospital，State Key Lab of Trauma，Burn and Combined Injury，Chongqing Key Laboratory for Disease Proteomics，Third Military Medical University (Army Medical University)；Tianjin Key Laboratory of Composite and Functional Materials，School of Materials Science and Engineering，Tianjin University；Department of Chemistry，Korea University；Department of Rheumatology and Clinical Immunology，Army Medical Center，Third Military Medical University (Army Medical University)）.Regulating the microenvironment with nanomaterials：Potential strategies to ameliorate COVID-19[J].Acta Pharmaceutica Sinica B,2023,第9期 Yalan Wang¹，Qiubing Chen^2,3，Shuang Wu¹，Xinyu Sun¹，Runting Yin¹，Zhen Ouyang¹，Hao Yin^2,3,4,5,6，Yuan Wei¹（School of Pharmacy，Jiangsu University；Department of Urology，Frontier Science Centre for Immunology and Metabolism，Medical Research Institute，Zhongnan Hospital of Wuhan University，Wuhan University；Department of Pulmonary and Critical Care Medicine，Zhongnan Hospital of Wuhan University；Department of Pathology，Zhongnan Hospital of Wuhan University；RNA Institute，Wuhan University；Wuhan Research Centre for Infectious Diseases and Cancer，Chinese Academy of Medical Sciences）.Amelioration of ethanol-induced oxidative stress and alcoholic liver disease by in vivo RNAi targeting Cyp2e1[J].Acta Pharmaceutica Sinica B,2023,第9期 Aixue Li^1,2,3，Dan Li^2,3，Yongwei Gu^2,3，Rongmei Liu^1,2,3，Xiaomeng Tang^2,3，Yunan Zhao^2,3，Fu Qi^1,2,3，Jifu Wei^4,5,6，Jiyong Liu^1,2,3,7（College of Pharmacy，Shandong University of Traditional Chinese Medicine；Department of Pharmacy，Fudan University Shanghai Cancer Center；Department of Oncology，Shanghai Medical College，Fudan University；Department of Pharmacy，Jiangsu Cancer Hospital；Jiangsu Institute of Cancer Research；The Affiliated Cancer Hospital of Nanjing Medical University；Department of Pharmacy，Shanghai Proton and Heavy Ion Center）.Plant-derived nanovesicles：Further exploration of biomedical function and application potential[J].Acta Pharmaceutica Sinica B,2023,第8期 Xin Yue^1,2，Tingyu Liu¹，Xuecen Wang²，Weijian Wu³，Gesi Wen⁴，Yang Yi²，Jiaxin Wu³，Ziyang Wang⁵，Weixiang Zhan⁶，Ruirui Wu³，Yuan Meng¹，Zhirui Cao⁷，Liyuan Le⁸，Wenyan Qiu⁸，Xiaoyue Zhang²，Zhenyu Li¹，Yong Chen²，Guohui Wan³，Xianzhang Bu^3,9，Zhenwei Peng²，Ran-yi Liu¹（State Key Laboratory of Oncology in South China，Sun Yat-sen University Cancer Center；Department of Radiation Oncology，the First Affiliated Hospital，Sun Yat-sen University；School of Pharmaceutical Sciences，Sun Yat-sen University；Department of Clinical Research，Guangzhou Institute of Respiratory Health，the First Affiliated Hospital of Guangzhou Medical University；Department of Gastrointestinal Surgery，the First Affiliated Hospital，Sun Yat-sen University；Department of Oncology，the Sixth Affiliated Hospital，Sun Yat-sen University；Department of Traditional Chinese Medicine，the First Affiliated Hospital，Sun Yat-sen University；Zhongshan School of Medicine，Sun Yat-sen University；Laboratory of Chemical Oncogenomics，Guangdong Provincial Key Laboratory of Chemical Genomics，Peking University Shenzhen Graduate School）.Pharmacological inhibition of BAP1 recruits HERC2 to competitively dissociate BRCA1-BARD1, suppresses DNA repair and sensitizes CRC to radiotherapy[J].Acta Pharmaceutica Sinica B,2023,第8期 Dianyang Li¹，Wenying Yu²，Maode Lai^1,3（School of Basic Medicine and Clinical Pharmacy，China Pharmaceutical University；State Key Laboratory of Natural Medicines，China Pharmaceutical University；Department of Pathology，Research Unit of Intelligence Classification of Tumor Pathology and Precision Therapy，Chinese Academy of Medical Science(2019RU042)，Key Laboratory of Disease Proteomics of Zhejiang Province，Zhejiang University School of Medicine）.Towards understandings of serine/arginine-rich splicing factors[J].Acta Pharmaceutica Sinica B,2023,第8期 Lijuan Xue¹，Keanqi Liu¹，Caixia Yan²，Junling Dun³，Yexin Xu¹，Linlin Wu¹，Huizhu Yang¹，Huafang Liu¹，Lin Xie¹，Guangji Wang¹，Yan Liang¹（Key Lab of Drug Metabolism & Pharmacokinetics，State Key Laboratory of Natural Medicines，China Pharmaceutical University；Zhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research，Department of Clinical Pharmacy，the First Affiliated Hospital，Zhejiang University School of Medicine；Analytical Applications Center，Shimadzu (China) Co.Ltd.）.Schisandra lignans ameliorate nonalcoholic steatohepatitis by regulating aberrant metabolism of phosphatidylethanolamines[J].Acta Pharmaceutica Sinica B,2023,第8期 Ying Lu^1,2，Fan Shen^1,2，Wen-Qiang He^1,2，An-Qi Li^1,2，Ming-Hua Li³，Xiao-Li Feng³，Yong-Tang Zheng^1,2，Wei Pang^1,2（Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences/Key Laboratory of Bioactive Peptides of Yunnan Province，KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases，Center for Biosafety Mega-Science，Kunming Institute of Zoology，Chinese Academy of Sciences；University of Chinese Academy of Sciences；Kunming National High-level Biosafety Research Center for Non-human Primates，Center for Biosafety Mega-Science，Kunming Institute of Zoology，Chinese Academy of Sciences）.HR121 targeting HR2 domain in S2 subunit of spike protein can serve as a broad-spectrum SARS-CoV-2 inhibitor via intranasal administration[J].Acta Pharmaceutica Sinica B,2023,第8期 Chao Liu^1,2，Wei Liu^1,3，Yanhong Liu^1,2，Hongxia Duan^1,2，Liqing Chen^1,2，Xintong Zhang^1,2，Mingji Jin^1,2，Minhu Cui⁴，Xiuquan Quan⁴，Libin Pan¹，Jiachun Hu¹，Zhonggao Gao^1,2，Yan Wang¹，Wei Huang^1,2（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College；Beijing Key Laboratory of Drug Delivery Technology and Novel Formulations，Department of Pharmaceutics，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Histology and Embryology，Chongqing Key Laboratory of Neurobiology，Brain and Intelligence Research Key Laboratory of Chongqing Education Commission，Third Military Medical University；Department of Gastroenterology，Yanbian University Hospital）.Versatile flexible micelles integrating mucosal penetration and intestinal targeting for effectively oral delivery of paclitaxel[J].Acta Pharmaceutica Sinica B,2023,第8期 Huan Zhang，Jie Yang，Rongze Sun，Songren Han，Zhaogang Yang，Lesheng Teng（School of Life Sciences，Jilin University）.Microfluidics for nano-drug delivery systems：From fundamentals to industrialization[J].Acta Pharmaceutica Sinica B,2023,第8期 Mingli Duan^1,2,3,4,5，Yurui Jia^1,2,3,4,5，Lifang Huo^1,2,3,4,5,6，Yiting Gao^1,2,3,4,5，Jia Wang^1,2,3,4,5，Wei Zhang^6,2,3，Zhanfeng Jia^1,2,3,4,5（Department of Pharmacology，Hebei Medical University；Center of Innovative Drug Research and Evaluation，Institute of Medical Science and Health，Hebei Medical University；The Key Laboratory of Neural and Vascular Biology，Ministry of Education；The Key Laboratory of New Drug Pharmacology and Toxicology；The Hebei Collaboration Innovation Center for Mechanism，Diagnosis and Treatment of Neurological and Psychiatric Disease；Department of Pharmacology，Institute of Chinese Integrative Medicine，Hebei Medical University）.Potentiation of PIEZO2 mechanically-activated currents in sensory neurons mediates vincristine-induced mechanical hypersensitivity[J].Acta Pharmaceutica Sinica B,2023,第8期 Qingqing Xiao¹，Xiaotong Li¹，Chang Liu¹，Yuxin Jiang¹，Yonglong He¹，Wanting Zhang¹，Helena S.Azevedo²，Wei Wu³，Yuanzheng Xia⁴，Wei He¹（School of Pharmacy，China Pharmaceutical University；School of Engineering and Materials Science，Institute of Bioengineering，Queen Mary University of London；School of Pharmacy，Fudan University；Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines，School of Traditional Chinese Pharmacy，China Pharmaceutical University）.Improving cancer immunotherapy via co-delivering checkpoint blockade and thrombospondin-1 downregulator[J].Acta Pharmaceutica Sinica B,2023,第8期 Shiwen Song¹，Dong Sun¹，Hong Wang^1,2，Jinliang Wang³，Huijing Yan³，Xuan Zhao³，John Paul Fawcett¹，Xin Xu¹，Deqi Cai^1,4，Jingkai Gu^1,4,5（Research Center for Drug Metabolism，School of Life Sciences，Jilin University；Center for Food and Drug Inspection of NMPA；Jen Kem Technology Co.Ltd.；State Key Laboratory of Supramolecular Structure and Materials，College of Chemistry，Jilin University；Beijing Institute of Drug Metabolism）.Full-profile pharmacokinetics, anticancer activity and toxicity of an extended release trivalent PEGylated irinotecan prodrug[J].Acta Pharmaceutica Sinica B,2023,第8期 Ke Yang^1,2，Lei Xu^1,2，Ying Xu^1,3，Qian Shen^1,2,4，Tao Qin^1,3,5，Yunfang Yu^1,3,5，Yan Nie^1,5，Herui Yao^1,3,5，Xiaoding Xu^1,2（Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation，Medical Research Center，Sun Yat-sen Memorial Hospital，Sun Yat-sen University；Nanhai Translational Innovation Center of Precision Immunology，Sun Yat-sen Memorial Hospital；Department of Oncology，Sun Yat-sen Memorial Hospital，Sun Yat-sen University；Department of Clinical Pharmacology，the Second Affiliated Hospital，University of South China；Breast Tumor Center，Sun Yat-sen Memorial Hospital，Sun Yat-sen University）.Nanoparticles（NPs）-mediated lncBCMA silencing to promote eEF1A1 ubiquitination and suppress breast cancer growth and metastasis[J].Acta Pharmaceutica Sinica B,2023,第8期 Bo-Yun Han¹，Zi-Long Wang¹，Junhao Li²，Qing Jin^1,3，Hao-Tian Wang¹，Kuan Chen¹，Yang Yi¹，Hans ?gren²，Xue Qiao¹，Min Ye^1,4（State Key Laboratory of Natural and Biomimetic Drugs，School of Pharmaceutical Sciences，Peking University；Department of Physics and Astronomy，Uppsala University；College of Life Science，Anhui Agricultural University；Peking University-Yunnan Baiyao International Medical Research Center）.A highly selective C-rhamnosyltransferase from Viola tricolor and insights into its mechanisms[J].Acta Pharmaceutica Sinica B,2023,第8期 Haowei Liu¹，Qiuming Huang¹，Yunqi Fan¹，Bo Li¹，Xuemei Liu^1,2，Changhua Hu^1,2（College of Pharmaceutical Sciences，Southwest University；NMPA Key Laboratory for Quality Monitoring of Narcotic Drugs and Psychotropic Substances，Chongqing Institute for Food and Drug Control）.Dissecting the novel abilities of aripiprazole：The generation of anti-colorectal cancer effects by targeting Gαq via HTR2B[J].Acta Pharmaceutica Sinica B,2023,第8期 Yingying Hou^1,2，Min Chen^1,2，Yuan Bian^1,2，Xi Zheng^1,2，Rongsheng Tong^1,2，Xun Sun³（Department of Pharmacy，Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital，School of Medicine，University of Electronic Science and Technology of China；Personalized Drug Therapy Key Laboratory of Sichuan Province，School of Medicine，University of Electronic Science and Technology of China；Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province，Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology，West China School of Pharmacy，Sichuan University）.Advanced subunit vaccine delivery technologies：From vaccine cascade obstacles to design strategies[J].Acta Pharmaceutica Sinica B,2023,第8期 Fan Tong，Haili Hu，Yanyan Xu，Yang Zhou，Rou Xie，Ting Lei，Yufan Du，Wenqin Yang，Siqin He，Yuan Huang，Tao Gong，Huile Gao（Key Laboratory of Drug Targeting and Drug Delivery Systems，West China School of Pharmacy，Sichuan University）.Hollow copper sulfide nanoparticles carrying ISRIB for the sensitized photothermal therapy of breast cancer and brain metastases through inhibiting stress granule formation and reprogramming tumor-associated macrophages[J].Acta Pharmaceutica Sinica B,2023,第8期 Jo?o Moreira¹，Mariana Machado²，Mónica Dias-Teixeira^1,3，Ricardo Ferraz^2,4，Cristina Delerue-Matos¹，Clara Grosso¹（REQUIMTE/LAQV，Instituto Superior de Engenharia do Porto，Instituto Politécnico do Porto；Ciências Químicas e das Biomoléculas/CISA，Escola Superior de Saúde—Instituto Politécnico do Porto；NICiTeS—Núcleo de Investiga??o em Ciências e Tecnologias da Saúde，Escola Superior de Saúde Ribeiro Sanches；REQUIMTE/LAQV，Departamento de Química e Bioquímica Faculdade de Ciências，Universidade do Porto）.The neuroprotective effect of traditional Chinese medicinal plants——A critical review[J].Acta Pharmaceutica Sinica B,2023,第8期 Songya Zhang¹，Lin Zhang²，Anja Greule³，Julien Tailhades^3,4,5，Edward Marschall^3,4,5，Panward Prasongpholchai⁶，Daniel J.Leng⁶，Jingfan Zhang⁷，Jing Zhu¹，Joe A.Kaczmarski⁸，Ralf B.Schittenhelm^3,9，Oliver Einsle²，Colin J.Jackson^5,8，Fabrizio Alberti^6,7，Andreas Bechthold¹⁰，Youming Zhang¹，Manuela Tosin⁶，Tong Si¹，Max J.Cryle^3,4,5（CAS Key Laboratory of Quantitative Engineering Biology，Shenzhen Institute of Synthetic Biology，Shenzhen Institute of Advanced Technology，Chinese Academy of Sciences；Institut für Biochemie，Albert-Ludwigs-Universit?t Freiburg；Department of Biochemistry and Molecular Biology，the Monash Biomedicine Discovery Institute，Monash University；EMBL Australia，Monash University；ARC Centre of Excellence for Innovations in Peptide and Protein Science；Department of Chemistry，University of Warwick；School of Life Sciences，University of Warwick，Gibbet Hill Campus；Research School of Chemistry，the Australian National University；Monash Proteomics and Metabolomics Facility，Monash University；Institute of Pharmaceutical Sciences，Albert-Ludwigs-Universit?t Freiburg）.P450-mediated dehydrotyrosine formation during WS9326 biosynthesis proceeds via dehydrogenation of a specific acylated dipeptide substrate[J].Acta Pharmaceutica Sinica B,2023,第8期 Qing Pei¹，Bowen Jiang^1,2，Dengyuan Hao^1,2，Zhigang Xie^1,2（State Key Laboratory of Polymer Physics and Chemistry，Changchun Institute of Applied Chemistry，Chinese Academy of Sciences；School of Applied Chemistry and Engineering，University of Science and Technology of China）.Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics[J].Acta Pharmaceutica Sinica B,2023,第8期 Xiyue Shen^1,2，Kai Luo¹，Juntao Yuan¹，Junling Gao¹，Bingqing Cui¹，Zhuoran Yu¹，Zhongbing Lu¹（College of Life Science，University of Chinese Academy of Sciences；Institute of Respiratory Medicine，Tongji University School of Medicine）.Hepatic DDAH1 mitigates hepatic steatosis and insulin resistance in obese mice：Involvement of reduced S100A11 expression[J].Acta Pharmaceutica Sinica B,2023,第8期 Yao Yang¹，Zimu Li¹，Ping Huang¹，Jiachan Lin¹，Jinyuan Li²，Kexin Shi¹，Jiahui Lin¹，Jingwen Hu¹，Zhuoxian Zhao¹，Yongkang Yu^1,3，Hongzhong Chen¹，Xiaowei Zeng¹，Lin Mei³（Institute of Pharmaceutics，School of Pharmaceutical Sciences(Shenzhen)，Sun Yat-sen University；State Key Laboratory of Oncology in South China，Collaborative Innovation Center for Cancer Medicine，Sun Yatsen University Cancer Center；Tianjin Key Laboratory of Biomedical Materials，Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy，Institute of Biomedical Engineering，Chinese Academy of Medical Sciences，Peking Union Medical College）.Rapidly separating dissolving microneedles with sustained-release colchicine and stabilized uricase for simplified long-term gout management[J].Acta Pharmaceutica Sinica B,2023,第8期 Yunting Zhang，Min Jiang，Guangsheng Du，Xiaofang Zhong，Chunting He，Ming Qin，Yingying Hou，Rong Liu，Xun Sun（Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province，Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology，West China School of Pharmacy，Sichuan University）.An antigen self-assembled and dendritic cell-targeted nanovaccine for enhanced immunity against cancer[J].Acta Pharmaceutica Sinica B,2023,第8期 Huanhuan Pang^1,2，Zeping Hu¹（School of Pharmaceutical Sciences，Tsinghua-Peking Center for Life Sciences，Beijing Frontier Research Center for Biological Structure，Tsinghua University；Artemisinin Research Center，Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences）.Metabolomics in drug research and development：The recent advances in technologies and applications[J].Acta Pharmaceutica Sinica B,2023,第8期 Kailong Ji¹，Wei Liu¹，Weihang Yin¹，Xiangrong Kong²，Honghong Xu¹，Zeng-Wei Lai¹，Jing-Ya Li^1,2，Jian-Min Yue¹（State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；School of Chinese Materia Medica，Nanjing University of Chinese Medicine）.A new class of potent liver injury protective compounds：Structural elucidation, total synthesis and bioactivity study[J].Acta Pharmaceutica Sinica B,2023,第8期 Letian Li¹，Jiayi Hao¹，Yuhang Jiang¹，Pengfei Hao¹，Yuwei Gao¹，Jing Chen¹，Guoqing Zhang¹，Ningyi Jin¹，Maopeng Wang²，Chang Li¹（Research Unit of Key Technologies for Prevention and Control of Virus Zoonoses，Chinese Academy of Medical Sciences，Changchun Veterinary Research Institute，Chinese Academy of Agricultural Sciences；Wenzhou Key Laboratory for Virology and Immunology，Institute of Virology，Wenzhou University）.A micro-sized vaccine based on recombinant Lactiplantibacillus plantarum fights against SARS-CoV-2 infection via intranasal immunization[J].Acta Pharmaceutica Sinica B,2023,第7期 Dayong Zheng¹，Jun Li²，Han Yan¹，Gang Zhang³，Wei Li¹，Edward Chu⁴，Ning Wei⁴（School of Pharmacy，North China University of Science and Technology；Basic Medical Science College，Liaoning University of Traditional Chinese Medicine；Division of Biology and Biological Engineering，California Institute of Technology；Department of Oncology and Cancer Therapeutics Program，Montefiore Einstein Cancer Center，Albert Einstein College of Medicine）.Emerging roles of Aurora-A kinase in cancer therapy resistance[J].Acta Pharmaceutica Sinica B,2023,第7期首页上一页 2 3 4 5 6 下一页尾页共有11页，转到页

期刊文章列表